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ABSTRACT
Expression of the human cytomegalovirus (HCMV) IE1 and IE2 proteins is critical for the establishment of lytic infection and
reactivation from viral latency. Defining the mechanisms controlling IE1 and IE2 expression is therefore important for under-
standing howHCMV regulates its replicative cycle. Here we identify several novel transcripts encoding full-length IE1 and IE2
proteins during HCMV lytic replication. Two of the alternative major immediate early (MIE) transcripts initiate in the first in-
tron, intron A, of the previously definedMIE transcript, while others extend the 5= untranslated region. Each of the MIE tran-
scripts associates with polyribosomes in infected cells and therefore contributes to IE1 and IE2 protein levels. Surprisingly, dele-
tion of the core promoter region of the major immediate early promoter (MIEP) from a plasmid containing theMIE genomic
locus did not completely abrogate IE1 and IE2 expression. Instead, deletion of the MIEP core promoter resulted in increased ex-
pression of alternative MIE transcripts, suggesting that the MIEP suppresses the activity of the alternative MIE promoters. While
the canonical MIEmRNAwas the most abundant transcript at immediate early times, the novel MIE transcripts accumulated to
levels equivalent to that of the knownMIE transcript later in infection. Using two HCMV recombinants, we found that se-
quences in intron A of the previously definedMIE transcript are required for efficient IE1 and IE2 expression and viral replica-
tion. Together, our results identify new regulatory sequences controlling IE1 and IE2 expression and suggest that multiple tran-
scription units act in concert to regulate IE1 and IE2 expression during lytic infection.
IMPORTANCE
The HCMV IE1 and IE2 proteins are critical regulators of HCMV replication, both during primary infection and reactivation
from viral latency. This study expands our understanding of the sequences controlling IE1 and IE2 expression by defining novel
transcriptional units controlling the expression of full-length IE1 and IE2 proteins. Our results suggest that alternative promot-
ers may allow for IE1 and IE2 expression whenMIEP activity is limiting, as occurs in latently infected cells.
The human cytomegalovirus (HCMV) IE1 and IE2 proteins arecritical regulators of the viral replicative cycle. Both proteins
are immediately expressed upon infection and together stimulate
the expression of host and viral genes necessary for virus replica-
tion (1). IE2 acts as a general transcription factor that broadly
transactivates host genes and viral early and late genes to facilitate
virus replication (2–12). IE1 promotes transcription from the
HCMV genome by inhibiting histone deactylases (HDACs) (13–
15), which otherwise limit virus transcription by forming inhibi-
tory chromatin structures on the viral genome. Reexpression of
IE1 and IE2 is also thought to be critical for the reactivation of
quiescent HCMV genomes from latent infection. Thus, under-
standing the regulatory mechanisms controlling IE1 and IE2 ex-
pression is important to understand how HCMV regulates its rep-
licative cycle.
The mRNAs encoding the 72-kDa IE1 and 86-kDa IE2 proteins
are derived from a shared precursor RNA through alternative
splicing (16). The mature IE1 and IE2 transcripts share the same
first three exons (exons 1 through 3) but differ in their final exon.
Transcripts that include exon 4 encode the 72-kDa IE1 protein,
while transcripts that skip exon 4 and retain exon 5 encode the
86-kDa IE2 protein (17). Several IE1 and IE2 splice variants have
been identified. For example, IE1 transcript variants arise from
alternative splice donor and acceptor usage in exons 3 and 4, re-
spectively (16–19). Similarly, IE2 transcript variants arise from
alternative splicing within exon 5 (17). The proteins encoded by
these alternatively spliced transcripts differ in function from full-
length IE1 and IE2 proteins, highlighting the role of alternative
splicing in expanding the functions of proteins encoded by the
major immediate early (MIE) locus.
In addition to alternative splicing, multiple promoters direct
the transcription of several distinct RNAs from the MIE locus. The
most studied promoter in this region is the major immediate early
promoter (MIEP), whose activity is regulated by multiple cellular
and viral factors such as CREB/ATF, NF-B, SP1, pp71, pp65, and
pTRS1 (20–32). In addition, the IE1 and IE2 proteins themselves
regulate MIEP activity. While IE1 stimulates MIEP activity, IE2
binds a wild-type cis repression sequence (crs) located adjacent to
the MIEP transcription start site, inhibiting transcription initia-
tion (33–37). Alternative promoters in the MIE locus also control
expression of IE1 and IE2 transcript variants in specific contexts. A
promoter proximal to the IE2-specific exon 5 drives the expres-
sion of several truncated IE2 isoforms during the late stage of
infection (38–40). An additional promoter located 5= of the MIEP
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is active in latently infected human monocytes (41), suggesting
that MIE transcription may be driven by different promoters dur-
ing lytic and latent infections.
In this study, we identified several previously unrecognized
MIE transcripts encoding full-length IE1 and IE2 proteins that are
expressed during HCMV lytic infection. The novel IE1 and IE2
transcripts differed from the known MIE transcript in their tran-
scription start sites (TSSs), and thus their 5= untranslated regions
(5=UTRs). Sequences surrounding each transcription start site
possessed promoter activity that increased during HCMV infec-
tion. Each transcript was associated with polyribosomes (poly-
somes) in infected cells, suggesting that each contributes to IE1
and IE2 protein expression during infection. While the canonical
MIE transcript is the most abundant transcript encoding IE1 or
IE2 during the immediate early stage of infection, the novel MIE
transcripts accumulated as infection progressed. Two of the newly
identified transcripts initiated in the first intron (intron A) of the
known MIE transcript. Recombinant viruses lacking intron A or
the region surrounding one of the “intronic” promoters expressed
lower levels of IE1 and IE2 mRNA and protein and replicated less
efficiently than the parental virus did. Together, our data show
that multiple transcripts encode full-length IE1 and IE2 proteins
during HCMV infection and suggest that multiple transcription
units act in concert to regulate IE1 and IE2 expression during lytic
replication.
MATERIALS AND METHODS
Cells and viruses. Primary human foreskin fibroblasts (HFFs), MRC-5
fibroblasts, and HeLa cells were grown in Dulbecco modified Eagle me-
dium (DMEM) with 10% fetal bovine serum (FBS) and penicillin and
streptomycin. Unless otherwise indicated, bacterial artificial chromosome
(BAC)-derived HCMV AD169 strain containing a green fluorescent pro-
tein (GFP) reporter driven by the simian virus 40 (SV40) promoter was
used for all infections (42). The titers of cell-free virus were determined by
the 50% tissue culture infective dose (TCID50) method on MRC-5 fibro-
blasts.
Construction of recombinant viruses. Recombinant viruses were
constructed in the AD169 genomic background by BAC-mediated recom-
bineering as previously described (43–46). Briefly, the HCMVUTR378
BAC was constructed by amplifying a kanamycin cassette flanked by
FLP recombination target (FRT) sites with primers HCMVUTR378-
FRTKanF (Kan stands for kanamycin, and F stands for forward) (5=-
TGGTGACGATACTTTCCATTACTAATCCATAACATGGCTCTTT
GCCACAAACCACGTCGTGGAATGCC-3=) and HCMVUTR378-
FRTKanR (R stands for reverse) (5=-ATCGTGCTGTGCCTAAGTCT
GGCCTCCACTGTTAGGAGCAAGGAGCTGCCTCCCATGTGCAG
GTGCTG-3=), which contained 50-nucleotide homology arms flanking the
desired insertion site in the HCMV genome. The PCR product was electro-
porated into the recombination-competentE. coli EL250 strain, and recom-
binants were selected by growth on LB containing kanamycin and chlor-
amphenicol. The kanamycin cassette was removed by induction of Flp
recombinase with arabinose, leaving a 34-bp FRT sequence in place of the
265 bp surrounding the UTR378 transcription start site (nucleotides
174085 to 174349 deleted, according to the numbering in reference genome
FJ527563.1). The deletion of intron A was accomplished using a two-step recom-
binationapproach. Inthefirst step, theKanSacBgenewasamplifiedwithprimers
HCMVIntronA – KanSacBF (5=-GCGGCCGGGAACGGTGCATT
GGAACGCGGATTCCCCGTGCCAAGAGTGACAATTCGAGCTCGG
TACCCGG-3=) and HCMVIntronA – KanSacBR (5=-AGGGTCCATCT
TTCTCTTGGCAGAGGACTCCATCGTGTCAAGGACGGTGACATCC
CGGGAAAAGTGCCACC-3=), which contained 50-nucleotide homol-
ogy arms flanking intron A. Recombination with the AD169 genome re-
sulted in the replacement of intron A with the KanSacB cassette. Recom-
binants were selected by growth on LB plates containing kanamycin and
chloramphenicol. For the second step, the primers Exon1/2Fusion F and
R (F/R) (5 =-CGGCCGGGAACGGTGCATTGGAACGCGGA
TTCCCCGTGCCAAGAGTGACTCACCGTCCTTGACACGATGGAGT
CCTCTGCCAAGAGAAAGATGGACCCT-3= and 5=-AGGGTCCATC
TTTCTCTTGGCAGAGGACTCCATCGTGTCAAGGACGGTGAGTC
ACTCTTGGCACGGGGAATCCGCGTTCCAATGCACCGTTCCCG
GCCG-3=, respectively) were used to amplify a region spanning the exon
1/exon 2 splice junction using IE2 cDNA as a template. The KanSacB
cassette was then removed by a second round of recombineering using the
above PCR product. The recombinants were grown on LB agar with chlor-
amphenicol and 6% sucrose to select against colonies that retained the
SacB gene. Sucrose-resistant colonies were then screened for kanamycin
sensitivity to ensure loss of the kanamycin cassette. The resulting recom-
binant, HCMVIntronA contained a seamless fusion of exons 1 and 2.
(nucleotides 173738 to 174564 deleted, according to numbering in refer-
ence genome FJ527563.1). The absence of genomic rearrangements was
confirmed by restriction digestion of the recombinant BAC DNAs at each
step. No errors were detected when the 500 bp on either side of each
mutation were sequenced. To further confirm the absence of additional
errors, the entire genome of the parental strain and both recombinants
was sequenced. Next-generation sequencing libraries were prepared from
BAC DNA using the Nextera library preparation kit (Illumina), and the
libraries were sequenced on an Illumina MiSeq instrument. No changes
other than the intended mutations were detected in the recombinant ge-
nomes.
Quantitative real-time PCR analysis. Total RNA was extracted using
TRIzol according to the manufacturer’s directions as described previously
(47, 48). Briefly, cell pellets were resuspended in TRIzol and extracted
with chloroform, and RNA was precipitated with isopropanol. The RNA
was treated with Turbo DNase (Applied Biosystems) and quantified on a
NanoDrop spectrophotometer. For quantitative reverse transcriptase
PCR (qRT-PCR), cDNA was generated from 0.5 g total RNA using the
High Capacity cDNA reverse transcription kit (ThermoFisher) and ran-
dom hexamer primers. The abundance of each transcript was determined
using a real-time PCR machine (Bio-Rad) and SYBR Select master mix
(ThermoFisher). The abundance of each product was determined by
comparison to a standard curve generated from qPCR analysis of 10-fold
serial dilutions of a DNA standard specific for each primer pair. For com-
parative analysis of MIE transcript abundance, each of the UTR-specific
primer pairs were confirmed to (i) amplify only the specific UTR se-
quence, and not amplify the other MIE UTRs or HCMV BAC DNA (data
not shown), (ii) have similar real-time PCR efficiencies (95% efficiency
for each primer pair), and (iii) have a similar linear range of detection of
the appropriate DNA standard (linear between 108 and 102 copies; R2
0.97 for all experiments included in this work). Where indicated, phos-
phonoacetic acid (PAA) (Sigma) was used at a final concentration of 200
g/ml. The primers used for qRT-PCR were IE1 qPCR F/R (5=-CAAGTG
ACCGAGGATTGCAA-3= and 5=-CACCATGTCCACTCGAACCTT-3=,
respectively), IE2 qPCR F/R (5=-TGACCGAGGATTGCAACGA-3= and
5=-CGGCATGATTGACAGCCTG-3=, respectively), GAPDH qPCR F/R
(5=-CTGTTGCTGTAGCCAAATTCGT-3= and 5=-ACCCACTCCTCCA
CCTTTGAC-3=, respectively), UTR70 qPCR (5=-TAGCTGACAGACTA
ACAGAC-3=), exon2-3 qPCR (5=-GGTCACGGGTGTCTCGGGCCGT-
3=), UTR136 qPCR (5=-TTGACCTCCATAGAAGACAC-3=), UTR378
qPCR (5=-CGCATTTGGAAGACTTAAGG-3=), UTR136/378 qPCR Re-
verse (5=-CCTTGACACGATGGAGTCCT-3=), and UTR487 qPCR F/R
(5=-GCATTATGCCCAGTACATGACC-3= and 5=-GAAATCCCCGTGA
GTCAAACC-3=, respectively).
For gene-specific reverse transcription reactions, primers specific for
IE1 (exon 4) or IE2 (exon 5) were used in the cDNA synthesis step: exon 4
RT (5=-TCCTTTTTAGCACGGGCCTT-3=) and exon 5 RT (5=-CGCATC
CACCTCACTCTTCA-3=). The cDNA was then amplified by PCR using
the following reaction conditions: 94°C for 5 min, 30 cycles (with 1 cycle
consisting of 94°C for 30 s, 55°C for 30 s, and 72°C for 5 min), followed by
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a 7-min extension at 72°C. The following PCR primers were used: exon 4
Out (5=-TGAATTTCTCTTCCGTCTGG-3=), exon 4 In (5=-AACCTTAA
TCTGTTTGACGA-3=), exon 5 Out (5=-CTGCAAGAGTGGGTTGT
CAG-3=), exon 5 In (5=-CTGGGCGAGGATGTCACCGA-3=), UTR70
Out (5=-ACAGACTAACAGACTGTTCC-3=), UTR70 In (5=-TCCATGG
GTCTTTTCTGCAG-3=), UTR136 Out (5=-TGACCTCCATAGAAGACA
CC-3=), UTR136 In (5=-TTCCCCGTGCCAAGAGTGAC-3=), UTR378
Out (5=-CGCTGACGCATTTGGAAGAC-3=), UTR378 In (5=-TGTTCT
GATAAGAGTCAGAG-3=), UTR487 Out (5=-AAGTACGCCCCCTATT
GACG-3=), and UTR487 In (5=-CCCCTATTGACGTCAATGAC-3=).
PCR products were analyzed on agarose gels and visualized with ethidium
bromide on an imager (Bio-Rad). PCR products were also sequenced to
confirm the specificity of the PCR.
HCMV DNA was quantified essentially as described previously (49).
Briefly, infected-cell pellets were lysed in DNA extraction buffer (400 mM
NaCl, 10 mM Tris-HCl [pH 8.0], 10 mM EDTA) and digested with pro-
teinase K (10 mg/ml) overnight at 37°C. The lysates were extracted with
phenol-chloroform, digested with RNase A (10 mg/ml) for 1 h at 37°C,
and again extracted with phenol-chloroform. DNA was precipitated with
100% ethanol and resuspended in 10 mM Tris-HCl (pH 8.0). The number
of HCMV genomes was determined by comparing the threshold values to
a series of HCMV BAC DNA standards containing from 108 to 101 HCMV
genomes. Results were normalized to the total amount of DNA in the
sample using qPCR primers specific for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The primers used were UL99 qPCR F/R (5=-
GTGTCCCATTCCCGACTCG-3= and 5=-TTCACAACGTCCACCCAC
C-3=, respectively) and GAPDH qPCR F/R (listed above).
Plasmid construction. To generate the promoter reporter constructs,
the 500 nucleotides from 450 to 50 bp flanking each transcription
start site were amplified by PCR and cloned into the HindIII and NotI sites
of the pGL3-Basic vector (Promega) using Gibson cloning (NEB). The
primers used were pGL3 Basic UTR70 F/R (5=-TCTTACGCGTGCTAGC
CCGGCTATCGCCGATAGAGGCGACATCAAG-3= and 5=-TACCAA
CAGTACCGGAATGCCAAGGCGGGCCATTTACCGTCATTG-3=, re-
spectively), pGL3 Basic UTR136 F/R (5=-TCTACGCGTGCTAGCCCGG
GCCGTATGTTCCCATAGTAACGCC-3= and 5=-TACCAACAGTACCG
GAATGCCAGTGTCTTCTATGGAGGTCAAAACAG-3=, respectively),
pGL3 Basic UTR378 F/R (5=-TCTTACGCGTGCTAGCCCGGGCATCG
CCTGGAGACGCCATCCAC-3= and 5=-TACCAACAGTACGGAATGC
CAATTCGCGTGGAGATCCCACGTTATG-3=, respectively), and pGL3
Basic UTR487 F/R (5=-TCTTACGCGTGCTAGCCCGGGCACCACCGT
CCCCAGTGCCCGCAG-3= and 5=-TACCAACAGTACCGGAATGCCA
CAGAAAAGACCCATGGAAAGGAAC-3=, respectively). The inserted
region was sequenced to confirm the absence of mutations. To generate
the plasmid pSVHMIEP, the nucleotides 94 to 64 relative to the
canonical transcription start site in the MIEP were deleted from the pSVH
vector (50) (generously provided by Q. Tang) using PCR-mediated
mutagenesis and Gibson cloning. Primers pSVHMIEP F/R (5=-GGC
ACCAAAATCAACGGGACTTTCCATAGAAGACACCGGGACCGA
TCA-3= and 5=-GGAAAGTCCCGTTGATTTTGGTGCC-3=, respec-
tively) were designed to (i) flank the region to be deleted and (ii) contain
20 nucleotides of sequence complementary to the other primer. The plas-
mid was amplified by PCR, and the PCR product was circularized in a
subsequent Gibson reaction. The clones were sequenced to confirm the
absence of spurious mutations.
Luciferase assays. Luciferase assays were performed as described pre-
viously (51). Briefly, 200,000 HeLa cells were transfected with the indi-
cated plasmids using polyethylenimine (PEI) as the transfection reagent.
Forty-eight hours after transfection, the cells were lysed in 150 l of pas-
sive lysis buffer (Promega). Twenty microliters of lysate was mixed with
100 l of luciferase reagent (Promega), and luciferase was measured on a
luminometer (Molecular Devices). The luciferase results were normalized
to the amount of protein in each sample as determined by the Bradford
protein assay kit (VWR). Luciferase reactions were performed in dupli-
cate, and the graphs show the mean values of at least three biological
replicates performed on different days. In experiments using primary fi-
broblasts, 4  106 cells were electroporated with the reporter constructs
and replated into six-well dishes 2 days prior to infection with HCMV. At
the indicated time after infection, cells were harvested and analyzed as
described above.
Western blotting. Western blotting was performed essentially as de-
scribed previously (52). Briefly, cells were lysed in radioimmunoprecipi-
tation assay (RIPA) buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1
mM EDTA, 1% NP-40, 1% sodium deoxycholate) with cOmplete pro-
tease inhibitors (Roche) on ice for 15 min, and insoluble material was
removed by centrifugation at 21,000  g for 10 min. Protein concentra-
tion was measured by the Bradford assay, and equal amounts of protein
(20 g) were loaded in each lane. Sample buffer (45 mM Tris-HCl [pH
6.8], 30% glycerol, 2% sodium dodecyl sulfate [SDS], 150 mM dithiothre-
itol [DTT], and 180 M bromophenol blue) was added to each sample
prior to boiling at 95°C for 10 min. Insoluble material was removed by
centrifugation for 5 min in a microcentrifuge at 21,000  g, and the
samples were then resolved on SDS-polyacrylamide gels. Proteins were
transferred to nitrocellulose membranes (Amersham) and blocked in
Tris-buffered saline with Tween 20 (TBST) (20 mM Tris-HCl [pH 7.6],
140 mM NaCl, 0.1% Tween 20) with 5% nonfat milk for at least 1 h at
room temperature. For monoclonal antibodies, the membranes were in-
cubated with the indicated dilution of antibody in TBST with 1% bovine
serum albumin (BSA) for 1 h at room temperature. For polyclonal anti-
bodies, the membranes were incubated with the antibody in TBST with
5% BSA overnight at 4°C. Following incubation with primary antibody,
the membranes were washed thrice with TBST and then incubated with
horseradish peroxidase-coupled secondary antibodies for 1 h at room
temperature in TBST with 1% BSA. The membranes were then incubated
with WesternBright enhanced chemiluminescence (ECL) reagent (BioEx-
press) and imaged on a chemiluminescence detection system (Bio-Rad).
The following antibodies were used at the indicated dilution: ICP36
(UL44; Virusys), 1:1,000; tubulin (Sigma), 1:10,000; GFP (Roche),
1:2,000. The IE1 (53) (1:100), IE2 (54) (1:100), and pp28 (55) (1:100)
antibodies were a generous gift from the Shenk lab.
5= rapid amplification of cDNA ends. 5= rapid amplification of cDNA
ends (5= RACE) was performed using the RLM-RACE (Ambion) kit ac-
cording to the manufacturer’s protocol as previously described (47).
Briefly, total or polysome-associated RNA was treated with calf intestinal
phosphatase (CIP) to dephosphorylate uncapped or degraded RNAs. The
5= 7-methylguanosine cap was then removed by incubation with tobacco
acid pyrophosphatase (TAP). An RNA linker was ligated to the newly
exposed phosphate on the 5= end of the RNA and was then reverse tran-
scribed with random hexamer primers. Nested PCR was performed using
primers specific for the linker sequence ligated to the mRNA 5= end and
exon 2 of the MIE transcript. The primers used were 5= RACE Outer exon
2 (5=-TTCGGCCAACTCTGGAAACAGC-3=) and 5= RACE Inner exon 2
(5=-ATCAGGGTCCATCTTTCTCTTGG-3=). PCR products were visual-
ized by ethidium bromide staining on agarose gels, shotgun cloned into
the pCR-Blunt vector (Invitrogen), and sequenced by Sanger sequencing
at the University of North Carolina (UNC) Genome Analysis Facility.
Polysome isolation. Polysomes and polysome-associated RNAs were
isolated as described previously (47, 48). Briefly, at the time of harvest,
cells were incubated in normal growth medium containing 0.1 mg/ml
cycloheximide (CHX) for 10 min. The cells were then washed three times
with phosphate-buffered saline (PBS) containing CHX and lysed in 1 ml
of polysome buffer (20 mM Tris-HCl [pH 7.4], 140 mM KCl, 5 mM
MgCl2) containing 0.1% Triton X-100, 10 mM DTT, and 100 M CHX.
The lysate was passed five times through a 27-gauge needle to disrupt the
cells, and nuclei were pelleted by centrifugation for 5 min at 1,150 g. The
cytoplasmic lysate was then centrifuged for 10 min at 21,000  g in a
microcentrifuge to remove mitochondria and insoluble debris. The su-
pernatant was layered onto a linear 10 to 50% sucrose gradient prepared
in polysome buffer. The gradients were spun for 2 h in an SW40 rotor at
32,000 rpm without interruption, and the gradients were fractionated
Multiple Transcripts Encode Full-Length IE1 and IE2
October 2016 Volume 90 Number 19 jvi.asm.org 8857Journal of Virology
through a gradient fractionation system (Brandel) with continuous mon-
itoring of the optical density at 254 nm (OD254) (UA-6; Isco). Gradient
fractions containing polysomes were extracted with TRIzol and treated
with Turbo DNase (Applied Biosystems), and the RNA was converted to
cDNA as described above.
RESULTS
Multiple mRNAs with different transcription start sites encode
full-length IE1 and IE2 proteins. In the course of identifying
splice junctions in HCMV transcripts using next-generation se-
quencing, we observed novel spliced transcripts in the major im-
mediate early (MIE) locus encoded on the same strand as the IE1
and IE2 reading frames (data not shown). These results suggested
the potential existence of undescribed IE1 and IE2 transcripts with
alternative 5= termini. We therefore performed 5= rapid amplifi-
cation of cDNA ends (5= RACE) analysis to identify transcription
start sites (TSSs) for mRNAs containing exon 2 of the MIE locus.
To focus on transcripts that were translated during infection, we
used polysome-associated RNA in the 5= RACE reactions. Cyto-
plasmic lysates of HCMV-infected cells were resolved through 10
to 50% linear sucrose gradients, and RNA was extracted from
fractions of the gradient containing polysomes. A representative
absorbance profile showing the location of polysomes in the gra-
dient is shown in Fig. 1A. For 5= RACE analysis, we used the RLM-
RACE procedure, wherein the mRNA cap is cleaved from mature
transcripts by tobacco acid pyrophosphatase (TAP) and replaced
with an RNA oligonucleotide containing a known sequence. Fol-
lowing random-hexamer-primed reverse transcription, the cDNA
was amplified using primers specific to the RNA oligonucleotide
sequence and exon 2 of the MIE transcript. Multiple bands were
present when the PCR products were visualized on agarose gels
(Fig. 1B), demonstrating that transcripts containing exon 2 are
associated with multiple 5= ends. No products were obtained in
the absence of TAP, demonstrating the specificity of the PCR for
mature, capped mRNAs.
To identify the 5= ends of the exon 2-containing transcripts, we
cloned and sequenced the PCR products of the 5= RACE reaction.
Herein we refer to each MIE transcript by the length of their 5=
untranslated region (UTR). In addition to the previously identi-
fied MIE TSS (referred to as UTR136) (56), multiple clones con-
taining additional 5= ends were found (Fig. 1C). One of the novel
transcription start sites (UTR487) was located 351 nucleotides 5=
of the start site of UTR136. Several clones identified a TSS previ-
ously observed in latently infected monocytes isolated from
HCMV-infected individuals (UTR406) (41). Transcripts initiat-
ing at this site have a 270-nucleotide extension of the 5= end of
exon 1 compared to the UTR136 start site. Two additional start
sites, UTR232 and UTR200, were located between the UTR406
TSS and the UTR136 TSS. Each of the above transcripts used the
previously described splice donor in exon 1 and splice acceptor in
exon 2 of the MIE transcript. The directionality of the splice donor
and acceptor sites confirmed that each transcript is encoded on
the same strand of the viral genome as the IE1 and IE2 open read-
ing frames (ORFs).
We also identified two transcripts that initiated in intron A of
the MIE locus. The first of these “intronic” transcripts, UTR378,
initiated in the middle of intron A, 350 nucleotides 3= of the ca-
nonical exon 1 splice donor site. This transcript used a unique
splice donor site with a canonical splice donor sequence (57) and
was spliced to the known splice acceptor in MIE exon 2. We also
found several clones containing transcripts that initiated 54 nu-
cleotides 5= of the splice acceptor site of MIE exon 2 (UTR70).
These results show that multiple transcription start sites give rise
to a collection of transcripts containing MIE exon 2. The associa-
tion of each transcript with polysomes suggests that the transcripts
are both trafficked to the cytoplasm and translated into protein
during HCMV infection.
Each of the new MIE transcripts included exon 2, which con-
tains the initiator methionine for both the IE1 and IE2 proteins
(16). To determine whether the novel MIE transcripts encoded
full-length IE1 or IE2 protein, we used reverse transcriptase PCR
(RT-PCR) to determine whether IE1- or IE2-specific sequence
(exon 4 or exon 5, respectively) was found on mRNAs originating
from each of the newly identified TSSs. We focused our analysis on
four transcript isoforms: (i) the longest transcript (UTR487), (ii)
the previously described MIE transcript (UTR136), and (iii) the
two transcripts initiating in intron A (UTR378 and UTR70). Total
or polysome-associated RNA was extracted from HCMV-infected
cells and reverse transcribed using primers specific for either IE1
(exon 4) or IE2 (exon 5). The resulting cDNA was amplified using
primers specific to exon 4 or exon 5 together with a primer recog-
nizing the individual transcript isoforms. No PCR product was
obtained from cDNA from uninfected cells or in the absence of
reverse transcriptase, demonstrating the specificity of each reac-
tion (Fig. 2A and B). In the presence of reverse transcriptase, PCR
FIG 1 Multiple transcription start sites give rise to mRNAs containing MIE exon 2. (A) HFFs were infected with HCMV (MOI of 3) and harvested at 72 h after
infection. Cytoplasmic lysates were resolved through a 10 to 50% linear sucrose gradient to separate ribosomal subunits (40S and 60S), monosomes (80S), and
polysomes. (B) 5= RACE was performed on RNA extracted from gradient fractions containing polysomes in the presence () or absence () of tobacco acid
pyrophosphatase (TAP). 5= RACE PCR products were visualized on agarose gels, cloned, and sequenced. (C) The cartoon shows the structures of the identified
transcripts (not to scale). The number to the right of each transcript indicates the length of the 5= untranslated region (UTR) of each transcript relative to the
translation start site (AUG) located in exon 2.
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products were obtained from both polysome-associated (Fig. 2A)
and total (Fig. 2B) cDNA for each 5= UTR linked to either IE1- or
IE2-specific exons. Each MIE transcript was also detected in total
RNA from cells infected with the HCMV TB40/E strain (Fig. 2C).
Sequence analysis of the amplicons confirmed that each transcript
contained exons 2 and 3 and was properly spliced to either exon 4
or exon 5 (data not shown). We conclude that transcripts arising
from each MIE transcription start site give rise to mature cytoplas-
mic transcripts encoding full-length IE1 or IE2 and that each tran-
script has the potential to contribute to IE1 and IE2 protein ex-
pression during infection.
To measure the temporal accumulation of each MIE tran-
script, we used quantitative reverse transcriptase PCR (qRT-PCR)
to measure the abundance of each transcript at different times
after infection. RNA was harvested at various times after infection,
and the abundance of each MIE transcript was determined by
comparison to a standard curve specific for each amplicon using
qRT-PCR (Fig. 3A). Each primer pair had a similar range of de-
tection and amplified its target with similar efficiency. The abun-
dance of the previously described MIE 5= UTR (UTR136) de-
creased between 6 and 24 h after infection (16) (Fig. 3A). UTR136
abundance did not return to initial levels until 96 h after infection.
The abundance of the UTR378 transcript increased fivefold be-
tween 6 and 48 h after infection, with a maximal increase at 96 h.
The longest transcript, UTR487, displayed a similar trend, but it
was even more abundant at 96 h than at the 6-h time point.
Temporal regulation of abundance and promoter activity of
alternative MIE transcripts. In comparing the abundance of the
different transcripts, the known MIE transcript (UTR136) was by
far the most abundant MIE transcript expressed 6 h after infec-
tion. However, by 72 h after infection, the UTR378 and UTR487
transcripts were expressed to at least the level of the UTR136 tran-
script. Thus, the UTR136 transcript is the most abundant MIE
transcript at immediate early times after infection. However, tran-
scription of the novel MIE transcript isoforms increases as infec-
tion progresses, eventually rivaling expression of the previously
described MIE transcript, UTR136. Like the UTR136 transcript,
UTR378 transcript abundance was increased in the presence of
cycloheximide. In contrast, cycloheximide significantly reduced
UTR487 abundance (Fig. 3B). To measure the role of viral DNA
replication in the accumulation of each MIE transcript, we mea-
sured the effect of phosphonoacetic acid (PAA), an inhibitor of
viral DNA replication, on MIE transcript abundance. PAA signif-
icantly inhibited accumulation of the novel MIE transcripts, with
FIG 2 Transcripts originating from each MIE transcription start site give rise to mature IE1 and IE2 mRNAs. Mock-infected (Mock) or HCMV-infected MRC-5
fibroblasts were harvested at 72 h after infection. (A) Polysome-associated RNA was extracted from AD169-infected cells and reverse transcribed using a primer
specific for either exon 4 (IE1) or exon 5 (IE2). The resulting cDNA was amplified using a primer specific for either IE1 or IE2 together with a primer specific for
each UTR (the primers are indicated by the length [in base pairs] of their their 5= UTR [UTR70, UTR136, UTR378, and UTR487]), and the PCR products were
visualized on agarose gels. Reverse transcriptase was omitted in a set of samples [(-)RT] to ensure the absence of contaminating DNA. (B) Total RNA was
extracted and analyzed as in panel A. (C) As in panel B, except cells were infected with the HCMV TB40/E strain (MOI of 3). The PCR products in panels A, B,
and C were cloned and sequenced to ensure their specificity.
FIG 3 Temporal analysis of MIE transcript abundance. (A) Primary fibroblasts were infected with HCMV (MOI of 3). The abundance of the indicated MIE
transcript at each time point was measured by qRT-PCR using the absolute abundance method as described in Materials and Methods. (B) Cells were infected
as described above for panel A in the presence of cycloheximide (gray bars) or absence of cycloheximide (black bars). The relative abundance of the indicated
transcript was measured by qRT-PCR at 6 h after infection. Transcript abundance in untreated cells was set at one. (C) Cells were infected as in panel A in the
presence (open bars) or absence (black bars) of PAA. Transcript abundance was measured by qRT-PCR using the absolute abundance method. Values that are
significantly different (P value 	 0.001) are indicated by a bar and asterisk. (D) Cells were infected and treated as in panel C. The reduction of UL99 mRNA
expression in the presence of PAA is shown for comparison. NT, not treated.
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a more pronounced effect on accumulation of the UTR378 and
UTR487 mRNAs (Fig. 3C). These data show that the newly iden-
tified MIE transcripts have a complex expression profile, which
together with the UTR136 transcript allows for continued IE1/2
transcription throughout the HCMV lytic cycle.
Sequences surrounding transcription start sites act as promot-
ers that recruit RNA polymerase to initiate transcription. To de-
termine whether the sequences surrounding the novel MIE tran-
scription start sites possessed promoter activity, we cloned the
region from450 to50 bp flanking each transcription start site
into a promoterless luciferase reporter vector (Fig. 4A) and mea-
sured luciferase expression after transfection into HeLa cells (Fig.
4B) or primary human fibroblasts (Fig. 4C). Each promoter re-
gion increased the amount of luciferase activity in both cell types
compared to the empty luciferase vector lacking a promoter, al-
though to various degrees. The reporter containing the MIEP was
the most active promoter, increasing luciferase expression by
49,000-fold compared to the empty vector (Fig. 4C). The least
active promoter segment was the region surrounding the UTR378
TSS, which resulted in a modest but consistent3-fold increase in
luciferase activity. The regions surrounding the UTR487 and
UTR70 transcription start sites had greater activity, increasing lu-
ciferase activity by 28- and 51-fold, respectively, compared to the
empty vector.
We next measured the effect of HCMV infection on the activity
of each promoter. Fibroblasts were electroporated with the re-
porter constructs and infected with HCMV, and luciferase activity
was measured over a time course of infection (Fig. 4D). Infection
had minimal effect on the activity of the UTR136 promoter, in-
creasing its activity by twofold throughout infection. Consistent
with our qRT-PCR analysis, each of the novel promoters was in-
duced by HCMV infection. Compared to uninfected cells, the
UTR70 promoter was induced 25-, 58-, and 50-fold at 24, 48, or 72
h after infection, respectively. At 24, 48, or 72 h after infection, the
UTR378 promoter was similarly induced 130-, 435-, and 470-fold,
respectively, and UTR487 was induced 5-, 20-, and 20-fold, re-
spectively (Fig. 4D). We conclude that the regions surrounding
the novel MIE transcription start sites have promoter activity that
is induced during HCMV infection.
The core promoter region of the MIEP is not necessary for
IE1 and IE2 expression outside the context of HCMV infection.
We next investigated whether the novel MIE promoters were ac-
tive outside of infection in the context of the MIE genomic locus.
The pSVH plasmid contains the region of the HCMV genome
from 840 nucleotides upstream of the MIEP transcription start
site to 1,413 nucleotides downstream of the polyadenylation sig-
nal following exon 5 (17). 5= RACE analysis of polysome-associ-
ated RNA from pSVH-transfected HeLa cells using a gene-specific
primer recognizing MIE exon 2 produced a single prominent
band (Fig. 5D). When the PCR product was sequenced, it was
found to correspond to the previously defined MIEP transcription
start site, UTR136. Thus, the UTR136 transcript is the predomi-
nant MIE transcript expressed from the MIE locus in uninfected
cells.
Previous studies found that the highly active MIEP can sup-
press the activity of weaker promoters by competing for RNA
polymerase II recruitment (58, 59). To determine whether pro-
moter competition might explain our failure to observe tran-
scripts arising from the alternative promoters in pSVH-trans-
fected cells, we generated a mutated version of the pSVH plasmid
FIG 4 DNA sequences surrounding the novel MIE transcription start sites have promoter activity. (A) Cartoon showing the location of the 500 nucleotide
regions tested for promoter activity. (B) HeLa cells were transfected with the indicated reporter plasmids, and luciferase activity was measured at 24 h after
transfection. The graph shows the fold change in luciferase (Luc) activity relative to cells transfected with the empty pGL3 Basic vector, which lacks a promoter
for the luciferase gene. (C) The indicated reporters were electroporated into MRC-5 fibroblasts, and luciferase activity was measured at 24 h after electroporation.
(D) MRC-5 fibroblasts were electroporated with the indicated reporters and then infected with HCMV (MOI of 3). Luciferase activity was measured at the
indicated times after HCMV infection. The graph shows the fold change in luciferase activity relative to the activity of each reporter at 6 h after infection. P-,
promoter.
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(pSVHMIEP) in which the core promoter region of the MIEP
(nucleotides 94 to 64 bp surrounding the transcription start
site) was deleted (Fig. 5A). Both IE1 and IE2 protein and mRNA
were expressed following pSVHMIEP transfection, albeit at sig-
nificantly reduced levels compared to the level in pSVH-trans-
fected cells (Fig. 5B and C, respectively). This could reflect in-
creased alternative promoter activity driven by a change in
proximity to the MIE enhancer. In any case, these data show that
the core promoter region of the MIEP is not required for IE1 and
IE2 expression from the MIE genomic locus outside the context of
infection.
5= RACE analysis of polysome-associated RNAs from
pSVHMIEP-transfected cells generated two PCR products, nei-
ther of which matched the size of the UTR136 5= UTR found in
cells transfected with wild-type pSVH. When the PCR products
were cloned and sequenced, they were found to correspond to the
UTR378 and UTR70 transcription start sites in intron A (Fig. 5D).
Thus, the regions flanking the alternative transcription start sites
in intron A have promoter activity that is sufficient to drive IE1
and IE2 expression in the context of the MIE genomic locus in the
absence of the MIEP. These data also suggest that promoter sup-
pression by the MIEP limits the activity of the intronic MIE pro-
moters.
Intron A of the MIE locus is important for efficient IE1 and
IE2 expression and HCMV replication. Our results suggested
that sequences in intron A contributed to the expression of IE1
and IE2. We therefore constructed an HCMV recombinant,
HCMVIntronA, wherein the entire intron A was deleted, leaving
a seamless fusion of exon 1 to exon 2 of the canonical MIE tran-
script. We also constructed a second recombinant, HCMV
UTR378, lacking the 250 nucleotides surrounding the transcrip-
tion start site for the UTR378 transcript (Fig. 6A). The entire
genome of each recombinant and the parental virus was rese-
FIG 5 The core promoter region of the MIEP is not necessary for IE1 and IE2
expression outside the context of HCMV infection. (A) Cartoon showing a
portion of the MIE locus in pSVH. The numbers show the locations of the MIE
transcription start sites for the indicated MIE transcripts shown in Fig. 1.
pSVHMIEP was created by removing a 158-bp region containing the MIEP
core promoter (94 to64 relative to the transcription start site). (B) HeLa
cells were left untransfected {negative control [(-) control]} or transfected with
pSVH or pSVHMIEP (MIEP). IE1 and IE2 protein levels were measured by
Western blotting at 24 h after transfection. (C) HeLa cells were transfected and
harvested as in panel B. The relative abundance of the IE1 and IE2 mRNAs in
pSVHMIEP-transfected cells compared to pSVH-transfected cells was deter-
mined by qRT-PCR using the CT method. IE1 and IE2 abundance in
pSVH-transfected cells is set at one. (D) HeLa cells were transfected as in panel
B. 5= RACE analysis of polysome-associated RNA was performed using gene-
specific primers located in exon 2. 5= RACE PCR products were visualized on
agarose gels and subsequently cloned and sequenced. No PCR products were
obtained in cells where tobacco acid pyrophosphatase (TAP) was omitted (),
demonstrating that the PCR products were derived from mRNAs containing a
5= m7G cap.
FIG 6 Removal of MIE intron A delays HCMV replication. (A) Diagram depicting the genomic regions removed from each recombinant HCMV BAC. (B)
MRC-5 fibroblasts were infected with wild-type (WT) HCMV, HCMVIntron A (Intron A), or HCMVUTR378 (UTR378) (MOI of 0.5). Cell-free virus was
quantified at the indicated times after infection by the TCID50 assay. (C) Fibroblasts were infected with HCMV (MOI of 3), and cell-free virus was quantified as
in panel B. Values that are significantly different (P	 0.05) from the WT value are indicated by an asterisk. (D) Fibroblasts were infected as in panel B, and the
relative abundance of viral DNA was quantified by real-time PCR at 72 h after infection. The amount of viral DNA in cells infected with wild-type virus was set
at one. Values that are significantly different (P	 0.001) from the WT value are indicated by an asterisk.
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quenced to confirm the absence of spurious mutations. Infectious
virus was recovered following electroporation of the recombinant
genomes into MRC-5 fibroblasts, demonstrating that neither in-
tron A nor the sequences surrounding the UTR378 promoter are
essential for virus replication (Fig. 6B).
To measure the effect of each mutation on virus replication, we
compared the replication kinetics of the wild-type and recombi-
nant viruses. Cells were infected at a multiplicity of infection
(MOI) of 0.5 or 3, and the accumulation of cell-free virus was
measured over a single round of virus replication. We observed
reduced accumulation of cell-free virus with both mutants at 72
and 96 h after infection at either multiplicity of infection, though
the effect was more pronounced at the lower multiplicity (Fig. 6B
and C). In addition, both recombinant viruses had a modest, but
reproducible, reduction in the accumulation of viral DNA (Fig.
6D). Thus, deletion of intron A or the region surrounding the
UTR378 promoter resulted in delayed replication kinetics com-
pared to wild-type virus.
To better define the defect in viral replication after low-multi-
plicity infection, we measured the accumulation of representative
immediate early, early, and late proteins after infection with the
recombinant viruses. Both recombinants expressed decreased lev-
els of the IE1 and E2 proteins compared to the wild-type virus. In
addition, the levels of the early protein pUL44 and the late protein
pp28 were expressed with delayed kinetics and to reduced levels
(Fig. 7A). The delayed replication of the HCMVIntron A and
HCMVUTR378 viruses thus correlated with decreased IE1 and
IE2 protein expression.
To determine whether the reduction in IE1 and IE2 protein
levels were the result of decreased IE1 and IE2 transcript levels, we
measured the accumulation of IE1 and IE2 transcripts after infec-
tion with each recombinant virus. Despite the presence of equiv-
alent numbers of viral genomes (Fig. 7B), IE1 and IE2 mRNA
levels were reduced in cells infected with the recombinant viruses
than in cells infected with the wild-type virus at early times of
infection (Fig. 7C). At late times after infection, both recombi-
nants expressed reduced levels of IE2 mRNA, but IE1 mRNA lev-
els were similar to those in cells infected with the wild-type virus
(Fig. 7C). Expression of the UTR136 transcript closely mirrored
IE1 expression; less UTR136 mRNA was present early after infec-
tion with either mutant, but its expression reached the same level
as in cells infected with wild-type virus by 72 h. Thus, the defect in
IE1 and IE2 mRNA levels correlated with a decrease in IE1 and IE2
protein expression. We conclude that sequences in intron A, and
the sequences surrounding the UTR378 TSS in MIE intron A, are
important for maximal expression of IE1 and IE2 and efficient
HCMV replication.
DISCUSSION
Proper regulation of IE1 and IE2 expression is critical for both
lytic and latent HCMV infection. In this study, we describe novel
IE1 and IE2 transcript isoforms arising from alternative transcrip-
tion start site usage. The novel transcripts encode full-length IE1
and IE2 proteins, but they differ from the previously described
MIE transcript in their 5= UTRs (Fig. 2). Several of the new tran-
script isoforms extended exon 1 of the previously described MIE
transcript, while two of the novel transcripts initiated within in-
tron A (Fig. 1). The DNA sequences surrounding the new tran-
scription start sites had promoter activity (Fig. 4B and C) that was
induced upon HCMV infection (Fig. 4D), consistent with the ac-
FIG 7 Deletion of MIE intron A results in decreased IE1 and IE2 mRNA and protein expression. (A) MRC-5 fibroblasts were infected with the indicated strains
of HCMV (MOI of 0.5). The expression of representative HCMV immediate early (IE1 and IE2), early (UL44), and late (pp28) proteins was measured by Western
blotting. (B) Fibroblasts were infected as in panel A. DNA was extracted from infected cells at 2 h after infection, and HCMV genome abundance was measured
by qPCR. (C) MRC-5 fibroblasts were infected as in panel A. The relative abundance of IE1, IE2, and UTR136 mRNAs in cells infected with each recombinant
virus was measured by qRT-PCR and compared to the levels in cells infected with wild-type HCMV, which was set at one. Values that are significantly different
(P	 0.05) from the WT value are indicated by an asterisk.
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cumulation of the novel transcript isoforms as infection pro-
gressed (Fig. 3A). Deletion of MIE intron A or the region sur-
rounding the UTR378 TSS in intron A delayed the production of
cell-free virus (Fig. 6B and C) and decreased IE1 and IE2 mRNA
and protein accumulation (Fig. 7). Together, these results suggest
that multiple transcription units within the MIE region control
the expression of full-length IE1 and IE2 proteins during lytic
virus replication.
Several spliced and alternatively spliced transcripts are tran-
scribed from the MIE locus (16–19). Many of the alternative IE1
and IE2 mRNAs encode truncated versions of the IE1 and IE2
proteins that have distinct roles in regulating HCMV gene expres-
sion (18, 19). Our results suggest that in addition, the MIE locus
gives rise to multiple transcripts encoding full-length IE1 and IE2
proteins. RT-PCR analysis of infected-cell RNA demonstrated
that each of the MIE transcription start sites was linked to both
exons 2 and 3, as well as the IE1- or IE2-specific exons (exon 4 or
5, respectively; Fig. 2A). The alternative transcripts were expressed
from both laboratory (AD169) and clinical (TB40/E) HCMV
strains (Fig. 2B and C) and thus likely are not the result of adap-
tation of the virus to in vitro passage. Each MIE transcript was
associated with polysomes in HCMV-infected cells, suggesting
that these transcripts contribute to IE1 and IE2 protein expression
(Fig. 2A). In addition, our results show that the upstream MIE
transcription start site previously found in latently infected mono-
cytes (UTR406 [41]) is also utilized during lytic infection (Fig. 1).
Thus, multiple transcription units contribute to the expression of
full-length IE1 and IE2 during lytic HCMV infection.
We also found that deleting either intron A of the MIE locus or
a portion of intron A containing one of the novel MIE promoters
decreased IE1 and IE2 mRNA and protein levels (Fig. 7) and de-
layed virus replication (Fig. 6B and C) without affecting viral entry
(Fig. 7B). These results are consistent with a role for the MIE
transcripts that initiate in intron A in the expression of IE1 and IE2
during infection. We obtained similar results with the smaller de-
letion of sequences surrounding the UTR378 start site. Interest-
ingly, while IE1 and UTR136 mRNA levels were similar at late
times after infection with the wild-type and deletion viruses, IE2
expression remained reduced at all time points (Fig. 7). This may
suggest that the alternative MIE transcripts are more important
for IE2 expression, particularly during the late stage of infection.
However, it is important to note that other undefined regulatory
elements could also be affected by these mutations and thus could
contribute to the observed decrease in IE1 and IE2 expression, as
suggested by the decreased expression of the UTR136 transcript at
early times after infection when intron A was deleted. Detailed
mapping of transcription factor binding sites and regulatory se-
quences controlling the intronic promoters together with a series
of subtle viral mutants will be needed to better define the factors
that regulate intronic promoter activity.
Our results suggest that the transcriptional regulation of full-
length IE1 and IE2 is more complex than previously appreciated.
We found that the MIE locus contains multiple promoters, in-
cluding two promoters located in intron A of the previously de-
scribed MIE transcript. This could explain results showing that the
presence of intron A modestly enhances the expression of down-
stream reporter genes (60–62). Perhaps this reflects a contribution
of the UTR378 and UTR70 promoters to transgene expression.
Our data also suggest that the coordinated regulation of the MIE
promoters allows for appropriate levels of IE1 and IE2 expression
throughout infection. The MIEP suppressed the weaker alterna-
tive MIE promoters in the context of the MIE locus (Fig. 5), which
correlates with the accumulation of the alternative MIE tran-
scripts later in infection when increased IE2 protein levels should
limit MIEP activity (32, 35, 37, 63). We also find that the UTR378
transcript can be transcribed in the presence of cycloheximide,
suggesting a potential role in the immediate early expression of
IE1 and IE2 as well (Fig. 3B). However, the contribution of this
transcript to IE1 and IE2 expression at IE times is likely to be
minor, as it is approximately 10-fold less abundant than the
UTR136 transcript at this time.
We also found that maximal accumulation of the alternative
MIE transcripts required viral DNA replication (Fig. 3C). The
promoters of herpesvirus late genes contain TATT motifs, which
are recognized by a complex of viral proteins that facilitate RNA
polymerase II recruitment (64, 65). Interestingly, TATT elements
are found approximately 30 nucleotides upstream of several of the
alternative MIE transcription start sites (UTR487, UTR406, and
UTR378; our unpublished observations), suggesting a role for
HCMV proteins in regulating the accumulation of the alternative
MIE transcripts. Thus, the specific sequence elements in the alter-
native MIE promoters may allow for the temporal or context-
specific regulation of IE1 and IE2 transcription.
Together, our data suggest a model for the regulation of IE1
and IE2 expression during HCMV infection. During the immedi-
ate early stage of infection, IE1 and IE2 transcription is controlled
primarily by the MIEP. As IE2 accumulates, it binds the crs se-
quence in the MIEP and represses MIEP promoter activity. Sup-
pression of the MIEP by IE2 allows the weaker promoters control-
ling expression of the UTR70 and UTR378 transcripts to become
active, which together account for the majority of the IE1 and IE2
transcripts made during the later stages of infection. The com-
bined action of the multiple MIE promoters thus allows for con-
tinued transcription of IE1 and IE2 despite the accumulation of
IE2 protein as infection progresses.
An interesting hypothesis arising from these results is that the
existence of multiple regulatory regions controlling IE1 and IE2
transcription might also contribute to cell-type- or context-de-
pendent expression. While our data suggest a role for the alterna-
tive MIE promoters in fibroblasts, perhaps the alternative MIE
transcription units play a more pronounced role in controlling
IE1 and IE2 expression in monocytes or macrophages where
MIEP activity is limited. The alternative promoters could also re-
spond to distinct environmental cues, similar to the situation for
ORF50 of the gammaherpesviruses. The gammaherpesvirus Rta
protein is functionally analogous to IE2, transactivating viral gene
expression to drive lytic replication and reactivate from latency
(66–68). Multiple transcripts arising from at least three distinct
promoters regulate ORF50 expression in both Kaposi’s sarcoma-
associated herpesvirus (KSHV) and murid herpesvirus 68
(MHV68) (69), and each ORF50 promoter responds uniquely to
temporal and cell-specific cues (70, 71). Together with our data,
these results suggest that the use of alternative promoters may be a
common herpesvirus strategy to allow for the precise regulation of
herpesvirus IE gene expression. Future experiments will focus on
identifying the roles of specific sequence elements that regulate the
alternative MIE promoters and their roles in other cell types and
during latent infection.
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